Kalaris Therapeutics Inc (KLRS)
KLRS Stock Price Chart
Explore Kalaris Therapeutics Inc interactive price chart. Choose custom timeframes to analyze KLRS price movements and trends.
KLRS Company Profile
Discover essential business fundamentals and corporate details for Kalaris Therapeutics Inc (KLRS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jul 2020
Employees
14.00
Website
https://kalaristx.comCEO
Andrew Oxtoby
Description
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
KLRS Financial Timeline
Browse a chronological timeline of Kalaris Therapeutics Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.66.
Earnings released on 13 Aug 2025
EPS came in at -$0.61 falling short of the estimated -$0.51 by -19.61%.
Earnings released on 14 May 2025
EPS came in at -$2.52 falling short of the estimated -$0.78 by -223.08%.
Earnings released on 7 Mar 2025
Stock split effective on 16 Jan 2025
Shares were split 1 : 23 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Nov 2024
EPS came in at -$0.04 surpassing the estimated -$0.14 by +71.43%.
KLRS Stock Performance
Access detailed KLRS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.